Stanford study first to analyze individual’s genome for risk of diseases, responses to treatment

April 30, 2010

For the first time, researchers have used a healthy person’s complete genome sequence to predict his risk for dozens of diseases and how he will respond to several common medications.

The risk analysis, from the Stanford University School of Medicine, also incorporates more-traditional information such as a patient’s age and gender and other clinical measurements.

The resulting, easy-to-use, cumulative risk report will likely catapult the use of such data out of the lab and into the waiting room of average physicians within the next decade, say the scientists.

More info: Stanford University Medical Center news